Palabras clave
Masa muscular
Composición corporal
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Estimar la ocurrencia y los factores asociados a la dinapenia en mujeres adultas y ancianas con diabetes mellitus tipo 2. Métodos: Estudio transversal realizado en el ambulatorio de endocrinología de un hospital de Recife, entre julio/2022 y febrero/2023. Se definió dinapenia cuando la fuerza de prensión manual era inferior a 16 kg. Se recogieron características sociodemográficas, clínicas, antropométricas, de composición corporal y bioquímicas para determinar los factores asociados con la dinapenia, mediante análisis bivariados y regresión robusta de Poisson. Los datos fueron analizados mediante el software SPSS Statistics y el estudio fue aprobado por el Comité de Ética en Investigación. Resultados: Se analizaron datos de 164 mujeres con una edad media de 60,04 ± 9,02 años. Se identificó que el 20,1% presentaba dinapenia, y luego del análisis de regresión, esta condición se asoció con baja escolaridad (p=0,001), raza/color blanco (p=0,008), exceso de peso (p=0,015) y masa muscular reducida (p <0,001). Conclusión: En este estudio se observó una alta ocurrencia de dinapenia, asociada a diversos factores sociodemográficos, antropométricos y de composición corporal. Estos resultados resaltan la importancia de evaluar esta condición con el objetivo de minimizar los efectos adversos para la salud que la dinapenia puede provocar en esta población.
Referencias
AKHMEDOV D e BERDEAUX R. The effects of obesity on skeletal muscle regeneration. Front Physiol., 2013; 4: 1-12.
AMERICAN DIABETES ASSOCIATION. Standards of medical care in diabetes. Diabetes Care. 2023; 46 (Suppl 1): S216-S229. Disponível em: https://diabetesjournals.org/care/issue/46/Supplement_1. Acessado em: 10 de novembro de 2023.
ARAÚJO EM, et al. The use of the variable race/ color within public health: possibilities and limits. Interface Comunic Saúde Educ., 2009; 13: 383-94.
AROKIASAMY P e SELVAMANI Y. Age, socioeconomic patterns and regional variations in grip strength among older adults (50+) in India: Evidence from WHO's Study on Global Ageing and Adult Health (SAGE). Arch Gerontol Geriatr., 2018; 76: 100-105.
BARBOSA-SILVA TG, et al. Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: Results of the COMO VAI? Study. J Cachexia Sarcopenia Muscle, 2016; 7(2): 136–143.
BERTONI M, et al. Depressive symptoms and muscle weakness: a two-way relation? Exp Gerontol., 2018; 108: 87-91.
BORGES VS, et al. A nationwide study on prevalence and factors associated with dynapenia in older adults: ELSI-Brazil. Cad Saude Publica, 2020; 36(4): e00107319.
CASTANHEIRA M, et al. Associação de variáveis sóciodemográficas e compor-tamentais com a gordura abdominal em adultos: estudo de base populacional no Sul do Brasil. Cad Saúde Pública, 2003; 19 Suppl 1: S55-65.
CHEVAL B, et al. Association of early and adultlife socioeconomic circumstances with muscle strength in older age. Age Ageing, 2018; 47: 398-407.
COLLINS KH, et al. Obesity, metabolic syndrome, and musculoskeletal disease: Common inflammatory pathways suggest a central role for loss of muscle integrity. Front Physiol., 2018; 9.
CRUZ-JENTOFT AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019; 48(1): 16-31.
DOBRETSOV M, et al. Early diabetic neuropathy: Triggers and mechanisms. World J Gastroenterol., 2007; 13: 175e191.
FREITAS MM, et al. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Experimental Gerontology, 2020; 132: 110835.
FUCHS SC, et al. Reliability of race assessment based on the race of the ascendants: a cross-sectional study. BMC Public Health, 2002; 2: 1.
HICKS GE, et al. Absolute strength and loss of strength as predictors of mobility decline in older adults: the InCHIANTI study. Journals of Gerontology: Series A: Biomedical Sciences and Medical Sciences, 2012; 67(1): 66-73.
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Pesquisa nacional de saúde: 2019: percepção do estado de saúde, estilos de vida, doenças crônicas e saúde bucal: Brasil e grandes regiões. Rio de Janeiro: IBGE; 2020. Disponível em: https://www.pns.icict.fiocruz.br/wp-content/uploads/2021/02/liv101764.pdf. Acessado em: 10 de outubro de 2023.
INTERNATIONAL DIABETES FEDERATION. IDF Diabetes Atlas: 10TH edition. 2021. Disponível em: www.diabetesatlas.org. Acessado em: 14 de Junho de 2022.
KRENTZ AJ, et al. Insulin resistance: a risk marker for disease and disability in the older person. Diabet Med., 2013; 30(5): 535-48.
LINO VTS, et al. Handgrip strength and factors associated in poor elderly assisted at a primary care unit in Rio de Janeiro, Brazil. PLoS One, 2016; 11: e0166373.
MANINI TM e CLARK BC. Dynapenia and Aging: An Update. J Gerontol A Biol Sci Med Sci., 2012; 67(1): 28-40.
MCLEAN RR, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 2014; 69(5): 576-583.
MICHAUD M, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc., 2013; 14: 877-882.
MORETTO MC, et al. Association between race, obesity and diabetes in elderly community dwellers: data from the FIBRA study. Cad Saude Publica, 2016; 32(10): e00081315.
MORLEY JE, et al. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle, 2014; 5: 253-259.
ORGANIZAÇÃO PAN AMERICANA DA SAÚDE. XXXVI Reunión del Comitê Asesor de Ivestigaciones en Salud – Encuestra Multicêntrica – Salud Beinestar y Envejecimeiento (SABE) em América Latina e el Caribe. Informe preliminar. 2002. Disponível em: https://www1.paho.org/Spanish/HDP/HDR/CAIS-01-05.PDF. Acessado em: 20 de janeiro de 2021.
PARK SW, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: The health, aging, and body composition study. Diabetes, 2006; 55: 1813e1818.
RODRÍGUEZ-GARCÍA WD, et al. Prevalence of dynapenia and pre sarcopenia related to aging in adult community-dwelling Mexicans using two different cut-off points. Eur Geriatr Med., 2018; 9: 219-25.
RUIZ JCV, et al. Sarcopenia y dinapenia en pacientes con diabetes mellitus tipo 2 en un área rural de Castilla-La Mancha. REV CLÍN MED FAM., 2017; 10(2): 86-95.
SCOTT D, et al. Associations of sarcopenic obe-sity and dynapenic obesity with bone mineral density and incident fractures over 5-10 years in commu-nity-dwelling older adults. Calcif Tissue Int., 2016; 99(1): 30-42.
SERGI G, et al. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin. Nutr, 2015; 34(4): 667–673.
SILVA TAA, et al. Sarcopenia Associada ao Envelhecimento: Aspectos Etiológicos e Opções Terapêuticas. Rev Bras Reumatol., 2006; 46(6): 391-397.
SOCIEDADE BRASILEIRA DE DIABETES. Diretrizes da sociedade brasileira de diabetes 2019-2020. Disponível em: https://diretriz.diabetes.org.br. Acessado em: 10 de outubro de 2022.
TUTTLE LJ, et al. Lower physical activity is associated with higher intermuscular adipose tissue in people with type 2 diabetes and peripheral neuropathy. Phys Ther., 2011; 91: 923-30.
WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995. Disponível em: https://iris.who.int/bitstream/handle/10665/37003/WHO_TRS_854.pdf?sequence=1&isAllowed=y. Acessado em: 11 de novembro de 2023.
WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, 3–5 June 1997 (1st ed.). Geneva: World Health Organization, 1998 WHO/NUT/NCD/98.1. Disponível em: https://iris.who.int/handle/10665/42330. Acessado em: 20 de junho de 2023.
YOON CH, et al. High glucose-induced jagged 1 in endothelial cells disturbs notch signaling for angiogenesis: A novel mechanism of diabetic vasculopathy. J Mol Cell Cardiol., 2014; 69: 52-66.